multigene panel hereditary cancer solution hcs v1 1 (Sophia Genetics)
Sophia Genetics is a verified supplier 
Sophia Genetics manufactures this product 
97
Structured Review
Sophia Genetics
multigene panel hereditary cancer solution hcs v1 1
Multigene Panel Hereditary Cancer Solution Hcs V1 1, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 373 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multigen-1/Hereditary+cancers/pmc12759264-41-10-18
Average 97 stars, based on 373 article reviews
Multigene Panel Hereditary Cancer Solution Hcs V1 1, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 373 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multigen-1/Hereditary+cancers/pmc12759264-41-10-18
Average 97 stars, based on 373 article reviews
multigene panel hereditary cancer solution hcs v1 1 - by Bioz Stars,
2026-11
97/100 stars
Images
Related Articles
Analysis:Article Title: A Retrospective Investigation of Microsatellite Instability (MSI) Testing in a Tertiary Centre Genetic Laboratory Article Snippet: .. Hereditary cancer panel analysis was performed using a custom hereditary cancer panel (60 genes), Next-Generation Sequencing:Article Title: Characterization of Copy Number Variants in Hereditary Cancer Patients Through NGS Shows a Distinctive PALB2 Contribution to the Diagnostic Yield Article Snippet: Fluorometric quantification of nucleic acids was carried out with a Qubit dsDNA High Sensitivity kit (Thermo Scientific, Waltham, Massachusetts, United States). .. The entire study population was tested using the CE‐IVD NGS‐based Article Title: A Descriptive Molecular Case Series of Novel Variants in APC-associated Polyposis Article Snippet: .. Genomic deoxyribonucleic acid was extracted from peripheral blood samples and analyzed by NGS using the SOPHiA GENETICS Article Title: Dual radiation-induced sarcomas after breast cancer in a TP53 variant carrier. Article Snippet: Li–Fraumeni syndrome (LFS), first described by Li and Fraumeni [1], is a rare autosomal dominant condition caused by variants in the TP53 gene, commonly designated as the “guardian of the genome” [2].. The protein encoded by this gene, p53, was identified in 1979 [3].. This protein plays a critical role in maintaining genomic integrity by regulating cell cycle checkpoints and inducing arrest in response Abbreviations LFS Li–Fraumeni Syndrome RT Radiotherapy CT Chemotherapy RIM Radiation-induced malignancies DSB Double-strand DNA break Blood/Plasma/Serum Samples:Article Title: A Descriptive Molecular Case Series of Novel Variants in APC-associated Polyposis Article Snippet: .. Genomic deoxyribonucleic acid was extracted from peripheral blood samples and analyzed by NGS using the SOPHiA GENETICS Mutagenesis:Article Title: Dual radiation-induced sarcomas after breast cancer in a TP53 variant carrier. Article Snippet: Li–Fraumeni syndrome (LFS), first described by Li and Fraumeni [1], is a rare autosomal dominant condition caused by variants in the TP53 gene, commonly designated as the “guardian of the genome” [2].. The protein encoded by this gene, p53, was identified in 1979 [3].. This protein plays a critical role in maintaining genomic integrity by regulating cell cycle checkpoints and inducing arrest in response Abbreviations LFS Li–Fraumeni Syndrome RT Radiotherapy CT Chemotherapy RIM Radiation-induced malignancies DSB Double-strand DNA break Sequencing:Article Title: Dual radiation-induced sarcomas after breast cancer in a TP53 variant carrier. Article Snippet: Li–Fraumeni syndrome (LFS), first described by Li and Fraumeni [1], is a rare autosomal dominant condition caused by variants in the TP53 gene, commonly designated as the “guardian of the genome” [2].. The protein encoded by this gene, p53, was identified in 1979 [3].. This protein plays a critical role in maintaining genomic integrity by regulating cell cycle checkpoints and inducing arrest in response Abbreviations LFS Li–Fraumeni Syndrome RT Radiotherapy CT Chemotherapy RIM Radiation-induced malignancies DSB Double-strand DNA break Variant Assay:Article Title: Dual radiation-induced sarcomas after breast cancer in a TP53 variant carrier. Article Snippet: Li–Fraumeni syndrome (LFS), first described by Li and Fraumeni [1], is a rare autosomal dominant condition caused by variants in the TP53 gene, commonly designated as the “guardian of the genome” [2].. The protein encoded by this gene, p53, was identified in 1979 [3].. This protein plays a critical role in maintaining genomic integrity by regulating cell cycle checkpoints and inducing arrest in response Abbreviations LFS Li–Fraumeni Syndrome RT Radiotherapy CT Chemotherapy RIM Radiation-induced malignancies DSB Double-strand DNA break Multiplex Ligation-dependent Probe Amplification:Article Title: Dual radiation-induced sarcomas after breast cancer in a TP53 variant carrier. Article Snippet: Li–Fraumeni syndrome (LFS), first described by Li and Fraumeni [1], is a rare autosomal dominant condition caused by variants in the TP53 gene, commonly designated as the “guardian of the genome” [2].. The protein encoded by this gene, p53, was identified in 1979 [3].. This protein plays a critical role in maintaining genomic integrity by regulating cell cycle checkpoints and inducing arrest in response Abbreviations LFS Li–Fraumeni Syndrome RT Radiotherapy CT Chemotherapy RIM Radiation-induced malignancies DSB Double-strand DNA break In Silico:Article Title: Dual radiation-induced sarcomas after breast cancer in a TP53 variant carrier. Article Snippet: Li–Fraumeni syndrome (LFS), first described by Li and Fraumeni [1], is a rare autosomal dominant condition caused by variants in the TP53 gene, commonly designated as the “guardian of the genome” [2].. The protein encoded by this gene, p53, was identified in 1979 [3].. This protein plays a critical role in maintaining genomic integrity by regulating cell cycle checkpoints and inducing arrest in response Abbreviations LFS Li–Fraumeni Syndrome RT Radiotherapy CT Chemotherapy RIM Radiation-induced malignancies DSB Double-strand DNA break |